Cozzarini Cesare, Fiorino Claudio, Ceresoli Giovanni Luca, Cattaneo Giovanni Mauro, Bolognesi Angelo, Calandrino Riccardo, Villa Eugenio
Department of Radiochemotherapy, San Raffaele H Scientific Institute, Milan, Italy.
Int J Radiat Oncol Biol Phys. 2003 Mar 1;55(3):688-94. doi: 10.1016/s0360-3016(02)04117-2.
Investigating the correlation between dosimetric/clinical parameters and late rectal bleeding in patients treated with adjuvant or salvage radiotherapy after radical prostatectomy.
Data of 154 consecutive patients, including three-dimensional treatment planning and dose-volume histograms (DVHs) of the rectum (including filling), were retrospectively analyzed. Twenty-six of 154 patients presenting a (full) rectal volume >100 cc were excluded from the analysis. All patients considered for the analysis (n = 128) were treated at a nominal dose equal to 66.6-70.2 Gy (ICRU dose 68-72.5 Gy; median 70 Gy) with conformal (n = 76) or conventional (n = 52) four-field technique (1.8 Gy/fr). Clinical parameters such as diabetes mellitus, acute rectal bleeding, hypertension, age, and hormonal therapy were considered. Late rectal bleeding was scored using a modified Radiation Therapy Oncology Group scale, and patients experiencing >or=Grade 2 were considered bleeders. Median follow-up was 36 months (range 12-72). Mean and median rectal dose were considered, together with rectal volume and the % fraction of rectum receiving more than 50, 55, 60, and 65 Gy (V50, V55, V60, V65, respectively). Median and quartile values of all parameters were taken as cutoff for statistical analysis. Univariate (log-rank) and multivariate (Cox hazard model) analyses were performed.
Fourteen of 128 patients experienced >or=Grade 2 late bleeding (3-year actuarial incidence 10.5%). A significant correlation between a number of cutoff values and late rectal bleeding was found. In particular, a mean dose >or=54 Gy, V50 >or=63%, V55 >or=57%, and V60 >or=50% was highly predictive of late bleeding (p <or= 0.01). A rectal volume <60 cc and type of treatment (conventional vs. conformal) were also significantly predictive of late bleeding (p = 0.05). Concerning clinical variables, acute bleeding (p < 0.001) was significantly related to late bleeding, and a trend was found for hypertension (p = 0.11). After patients were grouped into those with V50 >or=63% and those with V50 <63% (DVH grouping), data were fitted with a Cox regression hazard model using DVH grouping, rectal volume, and the main clinical parameters as independent variables. Results of the analysis showed that DVH grouping (relative risk 3.3; p = 0.04) and acute bleeding (relative risk 7.1; p = 0.001) are independently predictive of late bleeding.
DVHs of the rectum are significantly correlated with late bleeding for patients irradiated at 66.6-70.2 Gy after radical prostatectomy.
研究根治性前列腺切除术后接受辅助或挽救性放疗患者的剂量学/临床参数与晚期直肠出血之间的相关性。
回顾性分析154例连续患者的数据,包括直肠的三维治疗计划和剂量体积直方图(DVH)(包括充盈情况)。154例患者中直肠(完整)体积>100 cc的26例被排除在分析之外。所有纳入分析的患者(n = 128)均接受名义剂量为66.6 - 70.2 Gy(ICRU剂量68 - 72.5 Gy;中位数70 Gy)的适形(n = 76)或传统(n = 52)四野技术(1.8 Gy/分次)治疗。考虑了诸如糖尿病、急性直肠出血、高血压、年龄和激素治疗等临床参数。采用改良的放射治疗肿瘤学组量表对晚期直肠出血进行评分,出血≥2级的患者被视为出血者。中位随访时间为36个月(范围12 - 72个月)。考虑了直肠平均剂量和中位剂量,以及直肠体积和接受超过50、55、60和65 Gy的直肠百分比(分别为V50、V55、V60、V65)。所有参数的中位数和四分位数作为统计分析的临界值。进行单因素(对数秩)和多因素(Cox风险模型)分析。
128例患者中有14例出现≥2级晚期出血(3年精算发病率10.5%)。发现多个临界值与晚期直肠出血之间存在显著相关性。特别是,平均剂量≥54 Gy、V50≥63%、V55≥57%和V60≥50%对晚期出血具有高度预测性(p≤0.01)。直肠体积<60 cc和治疗类型(传统与适形)也对晚期出血具有显著预测性(p = 0.05)。关于临床变量,急性出血(p < 0.001)与晚期出血显著相关,高血压存在一定趋势(p = 0.11)。在将患者分为V50≥63%组和V50<63%组(DVH分组)后,以DVH分组、直肠体积和主要临床参数作为自变量,将数据拟合到Cox回归风险模型中。分析结果表明,DVH分组(相对风险3.3;p = 0.04)和急性出血(相对风险7.1;p = 0.001)可独立预测晚期出血。
对于根治性前列腺切除术后接受66.6 - 70.2 Gy照射的患者,直肠DVH与晚期出血显著相关。